- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Tomographic US spots ventricular septal defect
Tomographic ultrasound imaging on 4D volumes of fetal chest obtained with spatiotemporal image correlation and color Doppler shows good retrieval of diagnostic cardiac planes in fetuses with ventricular septal defects, according to an Italian study.
Tomographic ultrasound imaging on 4D volumes of fetal chest obtained with spatiotemporal image correlation and color Doppler shows good retrieval of diagnostic cardiac planes in fetuses with ventricular septal defects, according to an Italian study.
Investigators retrospectively evaluated eight fetuses with ventricular septal defects (single in seven and double in one) between 20 and 33 weeks gestation. They found that all of the defects were correctly identified with interslice distance in the tomographic ultrasound imaging function ranging from 0.8 to 2 mm without the need to further manipulate the volume. The researchers say the findings may improve diagnostic accuracy for this condition. The study was reported in July in the Journal of Ultrasound in Medicine.
Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection
February 5th 2025Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.
Can AI Bolster Breast Cancer Detection in DBT Screening?
January 16th 2025In sequential breast cancer screening with digital breast tomosynthesis (DBT), true positive examinations had more than double the AI case score of true negative examinations and the highest positive AI score changes from previous exams, according to new research.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.
